Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Seel-A-Peel square 100mm
23855858535
|
Seel-A-Peel square 100mm | Skin Protectors | Stoma Appliances | No data available |
|
Seel-A-Peel square 150mm
23855858536
|
Seel-A-Peel square 150mm | Skin Protectors | Stoma Appliances | No data available |
|
Seffalair Spiromax 12.75microg / 100microg/dose dry pdr inh
0302000N0BQAABR
|
Seffalair Spiromax | Fluticasone propionate (Inhalation) | Respiratory System | No data available |
|
Seffalair Spiromax 12.75microg / 202microg/dose dry pdr inh
0302000N0BQABBS
|
Seffalair Spiromax | Fluticasone propionate (Inhalation) | Respiratory System | No data available |
|
Selegiline 19mg/5ml oral solution
0409010T0AAAIAI
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | No data available |
|
Selegiline 5mg/5ml oral solution
0409010T0AAAGAG
|
Selegiline hydrochloride | Selegiline hydrochloride | Central Nervous System | No data available |
|
Selenase 500micrograms/10ml solution for injection vials
0905050A0BBADAD
|
Selenase | Selenium | Nutrition and Blood | No data available |
|
Selenium 100micrograms/10ml solution for infusion vials
0905050A0AAAEAE
|
Selenium | Selenium | Nutrition and Blood | No data available |
|
Selenium-ACE tablets
091000000BBYDBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Self-Cath catheter male 18Ch
21020000871
|
Self-Cath catheter male 18Ch | Catheters | Appliances | No data available |
|
Self-Cath catheter male coude olive tip 6Ch-8Ch
21020000859
|
Self-Cath catheter male coude olive tip 6Ch-8Ch | Catheters | Appliances | No data available |
|
Self-Cath catheter male coude taper tip 8Ch-10Ch
21020000858
|
Self-Cath catheter male coude taper tip 8Ch-10Ch | Catheters | Appliances | No data available |
|
Self-Cath HydroGel catheter male 10Ch-16Ch
21020000853
|
Self-Cath HydroGel catheter male 10Ch-16Ch | Catheters | Appliances | No data available |
|
Self-Cath Plus catheter female 8Ch-16Ch
21020000820
|
Self-Cath Plus catheter female 8Ch-16Ch | Catheters | Appliances | No data available |
|
Self-Cath Plus catheter male 8Ch-16Ch
21020000810
|
Self-Cath Plus catheter male 8Ch-16Ch | Catheters | Appliances | No data available |
|
Self-Cath Plus catheter paediatric 6Ch
21020000823
|
Self-Cath Plus catheter paediatric 6Ch | Catheters | Appliances | No data available |
|
Selsun Blue Anti-dandruff Deep Cleansing 1% shampoo
190205500BCMNA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Selsun Blue Anti-dandruff Dual Action 1% shampoo
190205500BCMPA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Selsun Blue Anti-dandruff Replenishing 1% shampoo
190205500BCMQA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Semaglutide 1.5mg tablets
0601023AWAAAKAK
|
Semaglutide | Semaglutide | Endocrine System | No data available |
|
Semaglutide 4mg tablets
0601023AWAAALAL
|
Semaglutide | Semaglutide | Endocrine System | No data available |
|
Semaglutide 9mg tablets
0601023AWAAAMAM
|
Semaglutide | Semaglutide | Endocrine System | No data available |
|
Semi-Daonil 2.5mg tablets
0601021H0BBACAA
|
Daonil | Glibenclamide | Endocrine System | No data available |
|
Semprex 8mg capsules
0304010A0BBAAAA
|
Semprex | Acrivastine | Respiratory System | No data available |
|
Senease Eighteen Years Plus 7.5mg tablets
0106020V0BDAAAA
|
Senease | Sennosides | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.